FOXP3 and breast cancer: There is a significantly increased frequency of FoxP3+, CD25+ Tregs at the lesion or tumour site in patients with HPV-induced CIN and cervical cancer as well as in other types of cancer including ovarian, lung and breast cancer [36]–[38].